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CarrageenanAbstract Flacourtia montana and its related species have been used traditionally for the treatment
of various diseases. The present study evaluated the hepatoprotective, anti-inflammatory and
antioxidant activities of F. montana methanolic extract. The hepatoprotective effect of F. montana
was evaluated against paracetamol induced hepatotoxicity in Wistar rats. Administration of parac-
etamol (2 g/kg) showed a significant biochemical and histological deterioration in the liver of exper-
imental animals. Pretreatment with F. montana (200 and 400 mg/kg b.wt. p.o) significantly
(P 6 0.001) reduced the elevated levels of serum enzymes like serum glutamic-oxaloacetic transam-
inase (AST), serum glutamic-pyruvic transaminase (ALT), alkaline phosphatase (ALP) and
reversed the hepatic damage in the liver which evidenced the hepatoprotective activity. The anti-
inflammatory activity of F. montana was evaluated by carrageenan-induced paw edema and cotton
pellet-induced granuloma models. F. montana (200 and 400 mg/kg) showed a significant (P 6 0.001)
reduction in rat paw edema with 76.39% and 80.32%, respectively induced by carrageenan against
the reference anti-inflammatory drug ibuprofen (10 mg/kg) (83.10%). Oral administration of
F. montana (200 and 400 mg/kg) also significantly (P 6 0.001) reduced the granuloma mass
formation in cotton pellet granuloma method. The reducing power and hydrogen peroxide radical
scavenging were increased at increasing doses of F. montana. The results of the present
study demonstrate that the methanolic extract of F. montana possess hepatoprotective,
anti-inflammatory and antioxidant activities.
 2016 Publishing services provided by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Hepatotoxicity refers to liver dysfunction or liver damage that
is associated with an overload of drugs or xenobiotics such as
acetaminophen, cadmium chloride, ethanol, carbon tetrachlo-
ride (CCl4) and allyl alcohols.
1,2 The chemicals that cause liver
injury are called hepatotoxins or hepatotoxicants. Hepatotox-
210 C. Joshy et al.icants are exogenous compounds of clinical relevance and may
include overdoses of certain medicinal drugs, industrial chem-
icals, and natural chemicals like microcystins, herbal remedies
and dietary supplements.3,4 Certain drugs may cause liver
injury when introduced even within the therapeutic ranges.
Hepatotoxicity may result not only from direct toxicity of
the primary compound but also from a reactive metabolite
or from an immunologically-mediated response affecting hep-
atocytes, biliary epithelial cells and/or liver vasculature.5,6
Hepatotoxic response is expressed in the form of characteristic
patterns of cytolethality in specific zones of the acinus. Its
related symptoms may include jaundice or icterus appearance
causing yellowing of the skin, eyes and mucous membranes
due to high level of bilirubin in the extracellular fluid, pruritus,
severe abdominal pain, nausea or vomiting, weakness, severe
fatigue, continuous bleeding, skin rashes, generalized itching,
swelling of the feet and or legs, abnormal and rapid weight
gain in a short period of time, dark urine and light color stool.
The liver disorders are one of the serious health problems,
throughout the world. Hepatoprotection or antihepatotoxicity
is the ability to prevent damage to the liver.7,8 Hepatoprotec-
tive effect was studied against chemicals and drug induced hep-
atotoxicity in rats. Alcohol, CCl4, galactosamine, paracetamol,
isoniazid rifampicin, antibiotics, peroxidised oil, aflatoxin have
been used as hepatic agents.9
Inflammation is a part of the complex biological response
of body tissues to harmful stimuli, such as pathogens, dam-
aged cells, or irritants.10 It is a protective response that
involves immune cells, blood vessels, and molecular mediators.
The purpose of inflammation is to eliminate the initial cause of
cell injury, clear out necrotic cells and tissues damaged from
the original insult and the inflammatory process, and to initi-
ate tissue repair.11 Inflammation is beneficial when needed,
but it is disastrous when chronic. Chronic inflammation gener-
ates a constant supply of free radicals that overwhelm our
antioxidant defenses and damage DNA, aging us and causing
disease of every description. Inflammation can also be defined
as body reaction against injury or irritant.12 Microorganisms,
physical agents, chemicals, inappropriate immunological
responses, and tissue death are the factors that can stimulate
inflammation. Infectious agents such as viruses and bacteria
are some of the most common stimuli of inflammation.13
Since the beginning of human civilization, medicinal plants
have been used by mankind for its therapeutic value. Nature
has been a source of medicinal agents for thousands of years
and an impressive number of modern drugs have been isolated
from natural sources.14 The plant-based, traditional medicine
systems continue to play an essential role in health care, with
about 80% of the world’s inhabitants relying mainly on tradi-
tional medicines for their primary health care.15 The medicinal
properties of plants could be based on the antioxidant, antimi-
crobial antipyretic effects of the phytochemicals in them.16
According to World Health Organization, medicinal plants
would be the best source to obtain a variety of drugs. There-
fore, such plants should be investigated to better understand
their properties, safety and efficacy.17
Flacourtia montana J. Grah is a thorny tree that belongs to
the family flacourtiaceae. They are found in the evergreen and
semi-evergreen forests and endemic to the Western Ghats-
common trees in South, Central and South Maharashtra
Sahyadris.18 F. montana and its related species have been used
traditionally for the treatment of various diseases. F. montanahas not been studied extensively both for its pharmacological
as well as phytochemical properties. But related species of F.
montana, Flacourtia jangomas, Flacourtia sepiaria, Flacourtia
inermis and Flacourtia ramontchi have been reported with var-
ious pharmacological activities like antibacterial, antidiabetic,
anti-inflammatory and hepatoprotective.19–21 Hence this study
was designed to evaluate the hepatoprotective, anti-
inflammatory and antioxidant activities of F. montana leaves
methanolic extract.2. Materials and methods
2.1. Plant material
The plant material was collected during the month of January,
2015, from Alappuzha district in Kerala, India. The plant was
taxonomically identified and authenticated by Dr. Kiranraj M.
S. Assistant Professor of Botany S. N College, Cherthala. A
voucher specimen was deposited at the Herbarium of Depart-
ment of Botany with accession No. SNCCH089 for future
reference.
2.2. Preparation of methanolic extract of F. montana leaves
Leaves were washed thoroughly with water to remove the soil
particles, shade dried and grounded. 1 kg of powder was
soaked in methanol sequentially for 72 h at room temperature.
Plant debris were removed from the extract by filtration and
defatted with petroleum ether and the filtrate was concentrated
under reduced pressure using a rotary evaporator at 40 C
until extraction solvent was completely dried. The yield of
methanol extract was 6.1 w/v. The extract was stored in the
refrigerator at 4 C for further use. The extract was dissolved
in normal saline and used for animal studies.
2.3. Experimental animals
Healthy male Wistar rats (150–180 g) were obtained from the
Animal house of Gov. Veterinary College, Mannuthy. They
were housed in polypropylene cages in a conducive environ-
mental situation i.e. temperature (22 ± 2 C), humidity (45
± 5 C) and 12 h of dark and light cycle. The animals were
fed with normal laboratory chow standard pellet diet. The ani-
mals were allowed to acclimatize for 7 days before commenc-
ing the experiments. All the studies were conducted in
accordance with the animal ethics committee of the institute
(IAEC, proposal number SJCP/IAEC/21/03/15/01) St.
Joseph’s college of pharmacy, Cherthala.
2.4. Acute toxicity study
To evaluate the toxicity of F. montana extract the acute toxic-
ity study was performed based on Irwin test.22 Four groups of
fasted healthy rats (six per group) were orally administered the
extract at a dose of 1–4 g/kg; the control group was given dis-
tilled water. The rats were observed for 1 h continuously and
then hourly for 4 h and finally after every 24 h up to 14 days
for any physical signs of toxicity, such as writhing, gasping,
palpitation and decreased respiratory rate or mortality. No
animals died. The animals showed some toxic behavior above
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Pre-screening investigation with 1/20th, 1/10th and 1/5th of
2000 mg/kg, i.e. 100, 200 and 400 mg was done. The doses
200 and 400 mg/kg were found to be effective against hepato-
protective and anti-inflammatory activities.
2.5. Evaluation of hepatoprotective activity
2.5.1. Induction of Paracetamol induced hepatotoxicity
Male Wistar rats weighing 150–180 g were used for the study.
Animals were divided into 5 groups of 6 animals each.
Group I: (normal control) received normal saline (1 ml/kg
b.wt. p.o.) for 5 days.
Group II: (toxic group) received saline (1 ml/kg b.wt. p.o.)
for 5 days and paracetamol (2 g/kg b.wt. p.o) on the 2nd and
3rd day.
Group III: (standard group) received Silymarin (100 mg/kg
b.wt. p. o.) for 5 days and paracetamol (2 g/kg b.wt. p.o.) on
the 2nd and 3rd day, 30 min after Silymarin administration.
Group IV: (test group), received methanolic extract of
F. montana (200 mg/kg b. wt. p.o) for 5 days and were admin-
istered paracetamol (2 g/kg b.wt. p.o.) on the 2nd and 3rd day,
30 min after methanolic extract administration.
Group V: (test group), received methanolic extract of
F. montana (400 mg/kg, b.wt. p.o) for 5 days and were admin-
istered paracetamol (2 g/kg b.wt. p.o.) on the 2nd and 3rd day
30 min after methanolic extract administration.23
Animals were sacrificed and blood was collected directly
through retro-orbital plexus. Serum was separated after coag-
ulating at 37 C for 30 min and centrifuged at 3000 rpm for
15–20 min. Serum was used for the estimation of biochemical
parameters like serum glutamate pyruvate transaminase
(AST), serum glutamate oxaloacetate transaminase (ALT)
and alkaline phosphatase (ALP) and the liver tissues collected
were subjected to histopathology. AST, ALT and ALP were
measured by using diagnostic kits.
2.5.2. Histopathological studies
Livers of different groups were fixed in 10% buffered neutral
formalin for 48 h and then with bovine solution for 6 h. Paraf-
fin sections were taken at 5 mm thickness, processed in
alcohol-xylene series and were stained with alum hematoxylin
and eosin. The sections were examined microscopically for
histopathological changes.23
2.6. Evaluation of anti-inflammatory activity of F. montana
2.6.1. Carrageenan induced paw edema
In this study the animals were divided into 4 groups of 4 rats
each. Group I: (normal control) rats received normal saline.
Group II: (standard group) received Ibuprofen (10 mg/kg b.
wt. p.o). Group III: (test group), received methanolic extract
of F. montana (200 mg/kg b.wt. p.o). Group IV: (test group),
received methanolic extract of F. montana (400 mg/kg b.wt.
p.o.).
The acute anti-inflammatory effect was evaluated by
carrageenan induced rat paw edema according to the method
of Winter et al.24 Edema was induced by injection of 1% sus-
pension of carrageenan in 0.9% sterile saline solution into the
right plantar region of the rat. F. montana (200 and 400 mg/kg)
and Ibuprofen (10 mg/kg b.wt.) were administrated orally 1 hbefore injection of carrageenan. Paw volume was measured
with plethysmometer at 1, 2, 3 and 4 h after injection. The inhi-
bitory activity was calculated using the following formula.25
Percentage inhibitionðPIÞ ¼ ðVt  VoÞcontrol
 ðVt  VoÞtreated=
ðVt  VoÞcontrol 100
Vo =Mean paw volume at 0 h, Vt = Mean paw volume at a
particular time interval
2.6.2. Cotton pellet-induced granuloma in rats
Male Wistar rats weighing 150–180 g were used for the study.
Group I: (normal control) rats received normal saline. Group
II: (standard group) received Ibuprofen (10 mg/kg b.wt.)
Group III: (test group) received methanolic extract of F. mon-
tana (200 mg/kg b.wt. p.o). Group IV: (test group) received
methanolic extract of F. montana (400 mg/kg b.wt. p.o).
A sterilized cotton pellet weighing 10 ± 1 mg was implanted
subcutaneously into the groin region of rats after which four
groups were treated (once daily) with 200 and 400 mg/kg of F.
montana for seven consecutive days. Animals in control and
standard groups received saline and Ibuprofen (10 mg/kg)
respectively. The animals were sacrificed on the 8th day. There-
after, the pellets surrounded by granuloma tissue were dissected
out carefully and the weights of wet cotton pellets were noted
and thereafter the cotton pellets were dried in an oven at 60
C for 24 h to obtain a dry cotton pellet weight and the mean
weight of granuloma tissue.26 The percentage inhibition (PI)
of granuloma tissue development was calculated:
PI ¼ Weight of pellet ðcontrolÞ
 weight of pelletðtestÞ=Weight of pelletðcontrolÞ  1002.7. Antioxidant activity
2.7.1. Reducing power assay
Reducing power was determined according to the method of
Oyaizu.27 10 mg of methanol extract and ascorbic acid, the
standard were dissolved in 10 ml of methanol. From the above,
different concentrations (100, 200, 300, 400 and 500 lg/ml)
were pipetted out and made up to 1 ml with distilled water.
2.5 ml of phosphate buffer (pH 6.6) and 2.5 ml of potassium
ferricyanide were added to each of the test tubes and incubated
at 40 ⁰C for 20 min. After incubation, 2.5 ml of trichloroacetic
acid was added and centrifuged for 5 min. To 2.5 ml of this
reaction mixture, 0.5 ml ferric chloride (0.1% w/v) and
2.5 ml of water were added. The absorbance was measured
at 700 nm using UV spectrophotometer.
2.7.2. Hydrogen peroxide scavenging assay
A solution of hydrogen peroxide (40 mM) was prepared in
phosphate buffer (50 mM, pH 7.4). 10 mg of F. montana and
ascorbic acid standard was dissolved in 10 ml of methanol.
Different concentrations of F. montana and ascorbic acid
(100, 200, 300, 400 and 500 lg/ml) was added to 0.6 ml hydro-
gen peroxide and absorbance at 230 nm was determined after
10 min against a blank solution containing phosphate buffer
without hydrogen peroxide.28 The percentage of hydrogen per-
oxide scavenging was calculated as:
212 C. Joshy et al.% scavenged ¼ ½ðAi AtÞ=Ai  100
where Ai is the absorbance of control and At is the absorbance
of test.
2.8. Estimation of total phenolic content
Total phenolic content was assessed according to the Folin–
Ciocalteau method. A standard curve was prepared using dif-
ferent concentrations of gallic acid (50, 100, 150, 200 and
250 mg/ml) in methanol. To the above standard solutions of
gallic acid (1 ml each), 5 ml Folin–Ciocalteau reagent (1:10
dilution in distilled water) was added and after 8 min, 4 ml
of 7.5% sodium carbonate was added. These solutions were
incubated at room temperature for 2 h and their absorbance
at 765 nm was measured spectrophotometrically. For the test
solution, 1 ml of F. montana methanolic extract (1 g in 10 ml
methanol) was added to 5 ml of Folin–Ciocalteau reagent.
4 ml of 7.5% sodium carbonate was added after 8 min and this
was incubated at room temperature for 2 h and its absorbance
was measured at 765 nm. The samples were tested in triplicate
and a calibration curve with five data points for gallic acid was
obtained. The results were compared to a Gallic acid calibra-
tion curve and the total phenolic content of F. montana
methanolic extract was expressed as mg of gallic acid equiva-
lents per gram of extract.29
2.9. Statistical analysis
Results were expressed as mean ± SEM. Statistical analyses of
all the data obtained were evaluated using a one-way ANOVA
followed by Dunnett’s post – hoc multiple comparison test
with SPSS Program; Version 20. All the results were also
expressed as graph by Graph Pad Prism software (v.5). P val-
ues 6 0.05 were considered as statistically significant.3. Results
3.1. Effect of F. montana on serum levels of AST, ALT and ALP
in hepatotoxic rats
In paracetamol induced hepatoxic study, after paracetamol
administration to the normal rats showed a significant increase
of AST, ALT and ALP levels. But methanolic extract of F.
montana (200 and 400 mg/kg) treatment brought the AST,
ALT and ALP levels significantly (P 6 0.001) to near normal
(Table 1).Table 1 Effect of F. montana on AST, ALT and ALP levels.
Groups
Normal control
Paracetamol (2 g/kg b.wt.)
Paracetamol (2 g/kg b.wt.) + Silymarin (100 mg/kg)
Paracetamol (2 g/kg b.wt.) + F. montana extract (200 mg/kg b. wt.)
Paracetamol (2 g/kg b.wt.) + F. montana extract (400 mg/kg b. wt.)
Results are expressed as mean ± SEM. The results were considered statis
with paracetamol, #P 6 0.05, ##P 6 0.01, ###P 6 0.001 compared with no3.2. Histopathological examination
Histopathological examination of liver sections of the control
group showed normal cellular architecture with distinct hep-
atic cells and central vein (Fig. 1–I). In the liver sections of
paracetamol intoxicated rats (Fig. 1–II), there was disarrange-
ment and degeneration of normal hepatic cells. The hepatic
cells also showed a small nucleus with necrosis; vacuolization
and inflammation. Treatment with F. montana extract (200
and 400 mg/kg) and silymarin, exhibited prominent protection
against paracetamol intoxication, which was evidenced by less
vacuole formation, less disarrangement and degeneration of
hepatocytes (Fig. 1III–V). Table 2 summarizes the data on
the degree of liver damage induced by paracetamol for each
group. The histoscores for vacuolization, inflammation and
cellular necrosis of the livers were significantly higher after
paracetamol treatment. In contrast, pretreatment with F. mon-
tana (400 mg/kg) and Silymarin (100 mg/kg) significantly
reduced the injury histoscores of the livers from these groups.
3.3. Effect of methanolic extract of F. montana on carrageenan
induced paw edema in rats
The effect of methanolic extracts of F. montana (200 and
400 mg/kg) in carrageenan induced paw edema in rats is shown
in Table 3. After carrageenan induction there was a significant
increase in edema formation in normal rats. Methanolic
extract at 200 mg/kg at 1, 2, 3 and 4 h prevented the car-
rageenan induced paw edema with a percentage inhibition of
18.62 ± 1.52, 42.24 ± 0.67, 67.11 ± 1.48, 76.39 ± 1.01 at 1,
2, 3 and 4 h respectively, while 29.65 ± 0.70, 58.39 ± 0.62,
69.54 ± 0.972, 80.32 ± 0.833 at a dose of 400 mg/kg at 1, 2,
3 and 4 h respectively. Ibuprofen decreased the carrageenan
induced paw edema with a percentage of 46.76 ± 1.12,
61.18 ± 0.88, 75.20 ± 1.15, 83.10 ± 1.21 at 1, 2, 3 and 4 h
respectively. The results showed that methanolic extract with
a dose of 200 and 400 mg/kg showed maximum inhibition sig-
nificantly (P 6 0.001) on carrageenan induced rat paw edema
at the end of 4 h compared to standard group rats.
3.4. Cotton pellet-induced granuloma in rats
The effect of methanolic extracts of F. montana (200 and
400 mg/kg) in cotton pellet induced granuloma in rats is shown
in Table 4. The results revealed that the methanolic extract of
F. montana shows a dose dependant inhibition of weight of
both wet and dry cotton pellets. The mean decrease in weightAST (IU/L) ALT (IU/L) ALP (IU/L)
32.70 ± 1.22 69.98 ± 3.4 37.53 ± 1.62
115.74 ± 3.4### 138.94 ± 1.4### 120.44 ± 2.72###
48.41 ± 1.3***,# 93.55 ± 1.0***,# 52.06 ± 1.14***,#
57.32 ± 0.58***,## 105.01 ± 0.44***,## 59.78 ± 0.52***,##
53.07 ± 0.67***,# 97.22 ± 0.62***,# 54.60 ± 0.29***,#
tically significant when *P 6 0.05, **P 6 0.01, ***P 6 0.001 compared
rmal control.
Figure 1 Histological section of Group I – Liver section of normal rats showing normal central vein (A) and radially arranged
hepatocytes (B). Group II – Liver section of hepatotoxic rats showing hepatocellular changes with small nucleus and necrosis (A);
vacuolization and inflammation (C). Group III – Liver section of standard treated group with normal central vein (A) and normal
hepatocytes (B). Group IV and Group V – Liver section of F. montana showed normal central vein (A) and radially arranged hepatocytes
with less vacuole formation.
Table 2 Histoscores of rat livers treated with F. montana and Silymarin in paracetamol-induced hepatotoxicity assay.
Histo-grade Groups
Control Paracetamol F. montana Silymarin 100 mg/kg
200 mg/kg 400 mg/kg
Vacuolization 0 3.3 ± 0.1## 2.4 ± 0.5* 1.44 ± 0.2** 1.5 ± 0.1**
Inflammation 0 2.8 ± 0.3## 1.93 ± 0.2** 1.58 ± 0.08** 1.6 ± 0.3**
Cellular necrosis 0 3.7 ± 0.3## 2.9 ± 0.3* 1.63 ± 0.4** 1.4 ± 0.09**
To quantify the histological indices for vacuolization and hepatocellular necrosis of liver, the slides were graded 0–4 according to the method of
Knodell et al. The liver damage was graded 0–4 as follows: 0 = no visible cell damage; 1 = slight (1–25%); 2 = moderate (26–50%);
3 = moderate/severe (51–75%); 4 = severe/high (76–100%).
#Significantly different from the control group (##P 6 0.01); *Significantly different from the paracetamol group (*P 6 0.05, **P 6 0.01); Values
are mean ± SEM (n= 6).
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and 400 mg/ kg body weight of the extract was significantly
(P 6 0.001) lower than those in the control rats. The extractwas found to be more effective at a dose of 400 mg/kg body
weight. The extract at the dose of 400 mg/kg had shown
61% inhibition in weight of wet cotton pellets and 67%
Table 3 Effect of F. montana on Carrageenan induced rat paw edema volume.
Groups Paw volume (cm)
1 h 2 h 3 h 4 h
Normal saline 0.43 ± 0.47 0.53 ± 0.33 0.61 ± 0.30 0.72 ± 0.45
Ibuprofen (10 mg/kg) 0.23 ± 0.49** 0.20 ± 0.47** 0.15 ± 0.71*** 0.12 ± 0.87***
F. montana extract (200 mg/kg) 0.35 ± 0.66* 0.31 ± 0.36* 0.20 ± 0.91** 0.17 ± 0.73**
F. montana extract (400 mg/kg) 0.31 ± 0.7* 0.22 ± 0.33** 0.18 ± 0.60*** 0.14 ± 0.60***
Results are expressed as mean ± SEM. The results were considered statistically significant when *P 6 0.05, **P 6 0.01, ***P 6 0.001 compared
with normal control.
Table 4 Effect of F. montana on cotton pellet granuloma.
Treatment group Mean of wet cotton pellets
(mg)
%
Inhibition
Mean of dry cotton pellets
(mg)
%
Inhibition
Mean of transudative
weight
Normal saline 190.32 ± 0.18 110.33 ± 0.19 79.98 ± 0.24
Ibuprofen (10 mg/kg) 60.67 ± 0.32*** 68% 30.56 ± 0.32*** 72% 30.10 ± 0.45***
F. montana extract
(200 mg/kg)
82.75 ± 0.51*** 56% 40.49 ± 0.43*** 63% 42.25 ± 0.54***
F. montana extract
(400 mg/kg)
73.99 ± 0.63*** 61% 35.93 ± 0.58*** 67% 38.06 ± 1.1***
Results are expressed as mean ± SEM. The results were considered statistically significant when *P 6 0.05, **P 6 0.01, ***P 6 0.001 compared
with normal control.
214 C. Joshy et al.inhibition in weight of dry cotton pellets, while the extract at
the dose of 200 mg/kg had shown 56% inhibition in weight
of wet cotton pellets and 63% inhibition in weight of dry cot-
ton pellets when compared to that of control group animals.
3.5. Reducing power of F. montana
Fig. 2 shows the reductive capabilities of F. montana compared
to the standard ascorbic acid. The reducing power increased
with increasing concentration of F. montana extract. The cor-
relation between concentration and reducing power of Ascor-
bic acid showed a significant positive correlation with a
coefficient of correlation 0.957 and also the correlation
between concentration and reducing power of F. montana0
0.2
0.4
0.6
0.8
1
1.2
1.4
100 200 300 400 500
A
bs
or
ba
nc
e
Concentration (μg/ml)
F. montana 
Ascorbic acid
r=0.957**
r=0.989***
Figure 2 Effect of F. montana on reducing power. Results are
expressed as mean ± SEM. The results were considered statisti-
cally significant when compared with concentration (**P 6 0.01,
***P 6 0.001).showed a significant positive correlation with a coefficient of
correlation 0.989.
3.6. Hydrogen peroxide scavenging activity of F. montana
The activity of F. montana on superoxide radical scavenging is
shown in Fig. 3. The scavenging ability of F. montana on
hydrogen peroxide is compared with that of standard ascorbic
acid. The IC50 value of F. montana on hydrogen peroxide scav-
enging activity was found to be 225.28 ± 1.79 lg/ml, whereas
the IC50values for ascorbic acid was found to be 98.27
± 0.25 lg/ml. The correlation between concentration and
hydrogen peroxide radical scavenging of Ascorbic acid showed
a significant positive correlation with a coefficient of0
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Figure 3 Hydrogen peroxide radical scavenging activity of F.
montana. Results are expressed as mean ± SEM. The results were
considered statistically significant when compared with concen-
tration (**P 6 0.01, ***P 6 0.001).
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tion and reducing power of F. montana showed a significant
positive correlation with a coefficient of correlation 0.984.
3.7. Total phenolic content of F. montana
The total phenolic content of methanol extract of F. montana
was 74.33 ± 4.93 mg gallic acid equivalent/gram extract calcu-
lated from the gallic acid calibration curve (fig. 4). The total
phenolic contents were calculated using the following linear
equation based on the calibration curve of gallic acid;
Y= 0.0015X+ 0.396, R2 = 0.9808 where Y is the absorbance
and X is the amount of gallic acid in lg.
4. Discussion
The present study was designed to establish the scientific evi-
dences for the usage of F. montana plant in hepatic and inflam-
matory conditions. Hepatoprotective effect was studied in
paracetamol induced hepatotoxicity and anti-inflammatory
effect in two models: carrageenan induced paw edema and cot-
ton pellet granuloma formation.
As far as liver diseases are concerned, traditional system of
medicine is highly hope giving. Paracetamol induced hepato-
toxicity is one of the well known and commonly used animal
models for studying the hepatoprotective property. Adminis-
tration of paracetamol at a dose of (1–3 g/kg/day, p.o) results
in hepatic damage and showed a significant elevation of serum
level of hepatic enzymes, AST, ALT and ALP. The toxic meta-
bolic N-acetyl-p-benzoquinoneimine is an oxidative product of
paracetamol formed by the action of cytochrome P-450 and it
reacts with paracetamol.30 N-acetyl-p-benzoquinoneimine
(NAPQI), which is one of the metabolites of paracetamol
which undergoes metabolism in the liver via the action of cyto-
chrome P450 monooxygenase,31–33 is highly responsible for the
paracetamol toxic effect to the liver. Histopathology of the
liver shows necrosis of the centrilobular hepatocytes character-
ized by nuclear pyknosis, eosinophilic and large excessive hep-
atic lesions.34 Liver injuries are often associated with a rise in
serum AST, ALT and ALP levels. In the present study, a sig-
nificant elevation in serum AST, ALT and ALP levels was
observed in paracetamol treated groups indicating hepatocel-
lular damage. Pre-treatment with Silymarin (100 mg/kg, p.o.)
and F. montana extract (200 and 400 mg/kg) caused a signifi-
cant reduction in elevated enzyme levels showing the hepato-
protective effect. Histopathological examination of livery = 0.0015x + 0.396
R² = 0.9808
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0 100 200 300
A
bs
or
ba
nc
e 
(7
65
nm
)
Concentration (mg/ml)
Absorbance(765nm)
Linear 
(Absorbance(765nm))
Figure 4 Standard curve of gallic acid standard at 765 nm.sections of F. montana treatment exhibited prominent protec-
tion against paracetamol intoxication, which was evidenced
by less vacuole formation and less disarrangement and degen-
eration of hepatocytes.
In addition to hepatoprotective activity, F. montana was
investigated in acute and sub acute inflammatory models for
anti-inflammatory activity. Carrageenan is a strong chemical
used for the release of inflammatory and proinflammatory
mediators (prostaglandins, leukotrienes, histamine, bradyki-
nin, TNF-a, etc).34 The carrageenan induced paw edema has
been accepted as a preliminary screening model for investigat-
ing systematic anti-inflammatory agent.35 The edema forma-
tion by sub plantar injection of carrageenan is a biphasic
response; initial phase (1 h) is being due to the release of sero-
tonin and histamine whereas the later phase (over 1 h) is attrib-
uted to the release of prostaglandins, the cyclooxygenase
products and the continuity between two phases is provided
by kinins.36,37 Methanolic extract of F. montana significantly
inhibited later phase of edema so it seems to be possible that
F. montana blocks prostaglandins and cyclooxygenase release
in the later phase of acute inflammation. The present results
indicate that F. montana (200 and 400 mg/kg) had an efficient
therapeutic activity in acute inflammatory conditions. In the
cotton pellet granuloma model, inflammation and granuloma
developed during a period of 7 days. The dry weight of the pel-
lets correlates with the amount of granulomatous tissue. Pro-
tein synthesis is necessary for the formation of granuloma.
Inflammation involves infiltration of macrophages, neu-
trophils and proliferation of fibroblasts, which are the basic
sources for granuloma formation.38,39 Consequently decrease
in granuloma weight indicates the suppression of the prolifer-
ative phase, which was effectively inhibited by the methanolic
extract of F. montana. F. montana (200 and 400 mg/kg)
appears to be equally effective to that of Ibuprofen in inhibit-
ing the dry weight of cotton pellets. Anti-inflammatory activity
of flavonoids, triterpenoids and phytosterols has been reported
so it might be possible that these particular phytoconstituents
from methanolic extract of F. montana could have contributed
to this activity.
Free radicals are harmful as they can participate in super-
fluous side reactions due to their chain reaction properties
which result in cell damage, blemishing of food, degradation
of various materials like rubber, gasoline etc. Life threatening
diseases for example cancer, stroke, and diabetes may occur as
a result of the consequences of free radicals. Antioxidants are
those molecules which can halt these chain reactions by remov-
ing free radical intermediates.42 H2O2 is rapidly decomposed
into oxygen and water and this may produce hydroxyl radicals
(OH-) that can initiate lipid peroxidation and cause DNA
damage in the body.40 The H2O2 scavenging activity of F. mon-
tana was evaluated and compared with ascorbic acid. The
maximum percentage scavenging of F. montana extract was
observed at 500 lg/ml concentration.
Phenolic compounds are responsible for antioxidant prop-
erties due to their ability to donate electrons resulting in the
conversion of highly reactive free radicals to nonreactive stable
molecules. Like flavonoids, tannins carry a high degree of free
radical scavenging property which may also be the prime rea-
son behind antioxidant activity.41 That is why total phenolic
content determination was important for making a correlation
between antioxidant property and amount of phenolics.42
From the present study we obtained a notable amount of
216 C. Joshy et al.phenolics which eventually supports its strong antioxidant
activity. The total phenolic content expressed in terms of
GAE was found to be 74.3 ± 4.93 mg of GA/g. Reducing
power assay is another established method for antioxidant
activity assessment. The reducing power assay was performed
first to investigate the Fe3+ to Fe2+ transformation in the
presence of F. montanamethanol extract.43 F. montantametha-
nol extract exhibited a proportional increase of absorbance
along with the concentration which proves the presence of
some active compounds that are capable of reacting with free
radicals and converting them to stable non reactive form as
well as terminating chain reactions.
Based on the role of paracetamol metabolite, N-acetyl-
p-benzoquinoneimine (NAPQI), the development of paraceta-
mol -induced hepatotoxicity seems to depend partly on the
existence of free radicals and oxidative processes. For that rea-
son, it is hypothesized that extract possessing free radical scav-
enging and/or antioxidant activities could also demonstrate
hepatoprotective activity against the paracetamol toxic effect.
This is supported by the claim that the combination of hepato-
protective effect and antioxidant activity synergistically pre-
vents the process of initiation and progress of hepatocellular
damage.44 The ability of F. montana to scavenge free radicals
and to exert antioxidant activity, which is concurrent with
our recent finding using reducing power assay, hydrogen per-
oxide assay. Moreover, the inflammatory processes activated
by toxic agents are intimately involved in the chemical-
induced hepatotoxic processes.45 The inflammatory processes
are thought to be responsible for producing various mediators,
which are involved in the production of ROS and NO that can
affect liver damage or repair. Therefore, it is also possible to
postulate that extracts possessing anti-inflammatory activity
might also exhibit hepatoprotective activity. The leaves of
F. montana also possess anti-inflammatory activity.
5. Conclusion
The methanolic extract of F. montana possesses hepatoprotec-
tive, anti-inflammatory and antioxidant activities. This knowl-
edge could be tapped to formulate new agents to treat liver and
inflammatory diseases.Conflict of interest
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